WTC Health Program Denies Peripheral Neuropathy for 9/11 Survivors and Responders

You might care about this because the Centers for Disease Control and Prevention (CDC) recently decided not to add a health condition called peripheral neuropathy to the World Trade Center (WTC) Health Program's list of covered illnesses. This decision impacts 9/11 responders and survivors who might be suffering from this condition. The WTC Health Program provides medical monitoring and treatment for people affected by the 9/11 terrorist attacks. It covers conditions linked to exposures at the New York City, Pentagon, and Shanksville sites. The Administrator of the program, who is the Director of the National Institute for Occupational Safety and Health (NIOSH), received three requests to add peripheral neuropathy to this list. After reviewing scientific and medical information, the Administrator concluded there was not enough evidence to support this addition at this time. This means the program will not move forward with steps like asking for a recommendation from a scientific committee or publishing a proposed rule to include peripheral neuropathy. The denial was issued on May 11, 2026. The program uses a detailed process to evaluate petitions, which includes reviewing peer-reviewed studies and assessing the causal link between 9/11 exposures and a health condition. For a condition to be added, there must be a substantial likelihood of a causal association. In this case, the evidence for peripheral neuropathy did not meet that standard. This document is particularly interesting because it shows the strict scientific process the WTC Health Program follows when deciding which health conditions qualify for coverage. It highlights the high bar for proving a direct causal link between 9/11 exposures and a specific illness. Even when petitions are submitted with some supporting studies, like the Marmor M, et al. [2020] study mentioned for peripheral neuropathy, the overall body of evidence must meet a substantial likelihood of causal association standard. This detailed evaluation process ensures that health benefits are provided based on strong scientific backing, protecting the integrity of the program. The decision to deny peripheral neuropathy also signals that initial studies, while showing an association, may not be conclusive enough to justify adding a condition for coverage. It reflects the careful balance between compassionate care for survivors and responders and the need for rigorous scientific proof. The process involves a Science Team that reviews studies for quality and evaluates them against specific criteria, including the Bradford Hill criteria, before making a recommendation to the Administrator. People who would be most interested in this legal document include 9/11 responders and survivors who may be suffering from peripheral neuropathy. Their eligibility for medical benefits under the WTC Health Program is directly affected by this decision. Legal professionals specializing in workers' compensation, personal injury, or administrative law would also find this document relevant, as it demonstrates how government health programs make coverage determinations. Public health officials and medical researchers studying the long-term health effects of environmental disasters, particularly the 9/11 attacks, would be interested in the scientific review process and the types of evidence considered sufficient or insufficient. Patient advocacy groups and non-profit organizations supporting 9/11 victims would closely follow such decisions, as they work to ensure comprehensive care for those affected. Finally, anyone interested in the administration of large-scale federal health programs and the scientific standards used to allocate resources would find this a valuable case study.